[조사자료] 글로벌 순환 종양 세포 (CTC) 시장 (2023-2030) : 임상/액체 생검, 연구

■ 영문 제목 : Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical/Liquid Biopsy, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV011 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 180 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 순환 종양 세포 (CTC) 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 순환 종양 세포 (CTC) 시장 규모는 2030년까지 275. 5억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 13. 34%의 CAGR로 성장할 것으로 전망됩니다. 진단 전, 치료 전, 치료 중, 치료 후 순환 종양 세포 (CTC)의 많은 잠재적 용도는 CTC 농축 및 분리 제품 개발에 참여하는 플레이어에게 유리한 성장 기회를 제공합니다. 연구 기관들은 효율성과 속도 측면에서 암 진단을 개선하기 위해 CTC 기반 검사를 개발하기 위한 노력을 기울이고 있습니다. 또한, 개인 맞춤형 의약품에 대한 수요 증가와 의약품 개발을 위한 연구 증가는 유전자 및 분자 수준에서 개인별 맞춤 치료를 제공할 것으로 예상됩니다. 예를 들어, 인디애나 대학교 의과대학이 2021년 10월에 실시한 조사 연구에 따르면, 수술 전 화학요법을 받은 여성의 혈장에 CTC와 순환 종양 DNA(ctDNA)가 존재한다는 사실이 밝혀졌습니다.

-삼중음성유방암 수술 전 화학요법을 받은 여성의 혈장 내 CTC와 순환종양 DNA(ctDNA)의 존재는 질병 재발을 예측하는 중요한 지표 중 하나입니다. 따라서 이러한 요인들은 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

또한, CTC 기반 액체 생검 검사는 비침습적이기 때문에 외상이 적고 회복이 빠르며, CTC 기반 액체 생검 검사는 비침습적이기 때문에 이 분야의 주요 이해관계자들의 자금 조달을 촉진할 것으로 예상됩니다. 또한, 종양 외과적 절제, 화학 요법, 방사선 요법을 포함한 복잡한 외과적 치료를 선택하기 전에 암의 최소 침습적 스크리닝을 지원하기 때문에 순환 종양 세포 (CTC)의 채택에 긍정적인 영향을 미칩니다.

희귀 암에 대한 제한된 적용이 수익 성장을 어느 정도 방해하고 있습니다. 순환 종양세포는 신경원성 암과 같이 EpCAM 음성 또는 저발현을 특징으로 하는 종양에는 적용할 수 없습니다. 예를 들어, 육종에 대한 순환 종양 세포 (CTC)의 특징을 보여주는 증거는 거의 없습니다. 반대로, 상피 항원을 표적으로 하는 항체를 이용한 방법 등 이러한 세포를 분리하기 위한 많은 방법들이 연구되고 있으며, 몇 년 후에는 이러한 문제를 극복할 수 있을 것으로 기대되고 있습니다.

그러나 최근 가치사슬의 형성과 시장 성장을 가속화하기 위해 대기업의 인수와 제약사와의 수많은 제휴를 통한 기술 일원화가 잇따르며 실용화가 추진되고 있습니다. 예를 들어, 워싱턴대학교 의과대학은 2023년 6월 시애틀에 본사를 둔 생명 공학 기업 레어사이트(RareCyte, Inc.)와 제휴해 전이암이 혈액으로 배출하는 종양세포를 검출하는 새로운 검사법을 개발했습니다. 연구에 따르면, 혈액 내 순환 종양 세포 (CTC)를 파악하면 종양 세포의 변화를 추적할 수 있어 치료를 최적화하는 데 도움이 될 수 있습니다.

순환 종양 세포 (CTC) 시장 보고서 하이라이트

- 기술별로는 CTC 검출 및 농축법이 CTC 농축 및 분리를 위한 제품의 가용성 증가와 전 세계적으로 높은 사용률 및 제품 보급률로 인해 2022년 65. 3%의 매출 점유율로 시장을 주도할 것으로 예상했습니다.

- 임상시험, 의약품 개발, 바이오마커 연구에 대한 CTC 분석의 적용 가능성이 높아짐에 따라 2023년부터 2030년까지 가장 높은 CAGR을 기록할 것으로 예상됩니다.

- 용도별로는 연구 분야가 2022년에 가장 큰 점유율을 차지하고 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 이는 암의 더 나은 치료를 위한 연구 수가 증가하고 있기 때문입니다.

- 제품별로는 고효율 자동화 시스템의 존재와 종양 세포 검출 시스템의 높은 활용률로 인해 장치 및 시스템 부문이 2022년 43.0%의 매출 점유율로 시장을 장악했습니다.

- 전혈 검체는 순환 종양 세포 (CTC)의 주요 공급원입니다. 그 결과, 이 부문은 2022년 46. 5%로 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 또한, 혈액 검체 부문은 예측 기간 동안 높은 성장률을 보일 것으로 예상됩니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변수/동향/범위
Chapter 4. 세계의 순환 종양 세포 (CTC) 시장 : 기술별 분석
Chapter 5. 세계의 순환 종양 세포 (CTC) 시장 : 용도별 분석
Chapter 6. 세계의 순환 종양 세포 (CTC) 시장 : 제품별 분석
Chapter 7. 세계의 순환 종양 세포 (CTC) 시장 : 표본별 분석
Chapter 8. 세계의 순환 종양 세포 (CTC) 시장 : 지역별 분석
Chapter 9. 경쟁 현황

■ 보고서 목차

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates & Forecasts Timeline
1.4. Objectives
1.4.1. Objective 1:
1.4.2. Objective 2:
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased database
1.6.2. GVR’s internal database
1.6.3. Secondary sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data analysis models
1.8. Marker Formulation & Validation
1.9. Market Model
1.9.1. Commodity flow analysis
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Advancements in chip technology
3.2.1.2. Expanding applications of CTCs
3.2.1.3. Growing demand for early and rapid cancer diagnosis
3.2.1.4. Growing incidence of cancer
3.2.2. Market Restraint Analysis
3.2.2.1. Consistency-related challenges in CTC detection and enrichment
3.2.2.2. Higher preference for Point-of-Care (POC) testing and non-availability of POC adaptable CTC tests
3.2.2.3. Lower applicability of CTCs in rare cancers
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.3.4. Pipeline Analysis
Chapter 4. Technology Business Analysis
4.1. Circulating Tumor Cells (CTCs) Market: Technology Movement Analysis
4.2. CTC Enrichment & Detection
4.2.1. CTC Enrichment & Detection Market, 2018 – 2030 (USD Million)
4.2.2. Immunocapture/label-based
4.2.2.1. Immunocapture/label-based Market, 2018 – 2030 (USD Million)
4.2.2.2. Immunocapture (label-based) Positive Selection
4.2.2.2.1. Immunocapture (label-based) Positive Selection Market, 2018 – 2030 (USD Million)
4.2.2.3. Immunocapture (label-based) Negative Selection
4.2.2.3.1. Immunocapture (label-based) Negative Selection Market, 2018 – 2030 (USD Million)
4.2.3. Size-based separation/label-free
4.2.3.1. Size-based separation/label-free Market, 2018 – 2030 (USD Million)
4.2.3.2. Membrane-based size separation (label-free)
4.2.3.2.1. Membrane-based size separation (label-free) Market, 2018 – 2030 (USD Million)
4.2.3.3. Microfluidic-based size separation (label-free)
4.2.3.3.1. Microfluidic-based size separation (label-free) Market, 2018 – 2030 (USD Million)
4.2.4. Density-based separation (label-free)
4.2.4.1. Density-based separation (label-free) Market, 2018 – 2030 (USD Million)
4.2.5. Combined methods (label-free)
4.2.5.1. Combined methods (label-free) Market, 2018 – 2030 (USD Million)
4.3. CTC Direct Detection
4.3.1. CTC Direct Detection Market, 2018 – 2030 (USD Million)
4.3.2. Microscopy
4.3.2.1. Microscopy Market, 2018 – 2030 (USD Million)
4.3.3. SERS
4.3.3.1. SERS Market, 2018 – 2030 (USD Million)
4.3.4. Others
4.3.4.1. Others Market, 2018 – 2030 (USD Million)
4.4. CTC Analysis
4.4.1. CTC Analysis Market, 2018 – 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Circulating Tumor Cells (CTCs) Market: Application Movement Analysis
5.2. Clinical/Liquid Biopsy
5.2.1. Clinical/Liquid Biopsy Market, 2018 – 2030 (USD Million)
5.2.2. Risk assessment
5.2.2.1. Risk Assessment Market, 2018 – 2030 (USD Million)
5.2.3. Screening and Monitoring
5.2.3.1. Screening and Monitoring Market, 2018 – 2030 (USD Million)
5.3. Research
5.3.1. Research Market, 2018 – 2030 (USD Million)
5.3.2. Cancer Stem Cell & Tumorgenesis Research
5.3.2.1. Cancer Stem Cell & Tumorgenesis Research Market, 2018 – 2030 (USD Million)
5.3.3. Drug/Therapy Development
5.3.3.1. Drug/Therapy Development Market, 2018 – 2030 (USD Million)
Chapter 6. Product Business Analysis
6.1. Circulating Tumor Cells (CTC) Market: Product Movement Analysis
6.2. Devices or Systems
6.2.1. Devices or Systems Market, 2018 – 2030 (USD Million)
6.3. Kits & Reagents
6.3.1. Kits & Reagents Market, 2018 – 2030 (USD Million)
6.4. Blood Collection Tubes
6.4.1. Blood Collection Tubes Market, 2018 – 2030 (USD Million)
Chapter 7. Specimen Business Analysis
7.1. Circulating Tumor Cells (CTC) Market: Specimen Movement Analysis
7.2. Blood
7.2.1. Blood Market, 2018 – 2030 (USD Million)
7.3. Bone Marrow
7.3.1. Bone Marrow Market, 2018 – 2030 (USD Million)
7.4. Other Body Fluids
7.4.1. Other Body Fluids Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Circulating Tumor Cells (CTC) Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Australia Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Thailand Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. South Korea Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Mexico Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Argentina Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. MEA Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. South Africa Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Saudi Arabia Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait Circulating Tumor Cells (CTC) Market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share/Positioning Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. QIAGEN
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Bio-Techne Corporation
9.4.2.1. Overview
9.4.2.1.1. Advanced Cell Diagnostics, Inc
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Precision for Medicine
9.4.3.1. Overview
9.4.3.1.1. ApoCell, Inc.
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. AVIVA Biosciences
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. BIOCEPT, INC.
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. BioCEP Ltd.
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Fluxion Biosciences, Inc.
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Greiner Bio One International GmbH
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Ikonisys Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Miltenyi Biotec
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. IVDiagnostics
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. BioFluidica
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. Canopus Bioscience Ltd.
9.4.13.1. Overview
9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. Biolidics Limited
9.4.14.1. Overview
9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Creatv MicroTech, Inc.
9.4.15.1. Overview
9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives
9.4.16. LungLife AI, Inc.
9.4.16.1. Overview
9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.16.3. Product Benchmarking
9.4.16.4. Strategic Initiatives
9.4.17. Epic Sciences
9.4.17.1. Overview
9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.17.3. Product Benchmarking
9.4.17.4. Strategic Initiatives
9.4.18. Rarecells Diagnostics
9.4.18.1. Overview
9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.18.3. Product Benchmarking
9.4.18.4. Strategic Initiatives
9.4.19. ScreenCell
9.4.19.1. Overview
9.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.19.3. Product Benchmarking
9.4.19.4. Strategic Initiatives
9.4.20. Menarini Silicon Biosystems
9.4.20.1. Overview
9.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.20.3. Product Benchmarking
9.4.20.4. Strategic Initiatives
9.4.21. LineaRx, Inc. (Vitatex, Inc.)
9.4.21.1. Overview
9.4.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.21.3. Product Benchmarking
9.4.21.4. Strategic Initiatives
9.4.22. Sysmex Corporation
9.4.22.1. Overview
9.4.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.22.3. Product Benchmarking
9.4.22.4. Strategic Initiatives
9.4.23. STEMCELL Technologies, Inc
9.4.23.1. Overview
9.4.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.23.3. Product Benchmarking
9.4.23.4. Strategic Initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Global CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 4 Global CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 5 Global Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 6 Global Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 7 Global CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 8 Global CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 9 Global CTC market, by application, 2018 - 2030 (USD Million)
TABLE 10 Global Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 11 Global Research market, by application, 2018 - 2030 (USD Million)
TABLE 12 Global CTC market, by product, 2018 - 2030 (USD Million)
TABLE 13 Global CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 14 North America CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 15 North America CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 16 North America Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 17 North America Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 18 North America CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 19 North America CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 20 North America CTC market, by application, 2018 - 2030 (USD Million)
TABLE 21 North America Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 22 North America Research market, by application, 2018 - 2030 (USD Million)
TABLE 23 North America CTC market, by product, 2018 - 2030 (USD Million)
TABLE 24 North America CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 25 U.S. CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 26 U.S. CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 27 U.S. Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 28 U.S. Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 29 U.S. CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 30 U.S. CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 31 U.S. CTC market, by application, 2018 - 2030 (USD Million)
TABLE 32 U.S. Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 33 U.S. Research market, by application, 2018 - 2030 (USD Million)
TABLE 34 U.S. CTC market, by product, 2018 - 2030 (USD Million)
TABLE 35 U.S. CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 36 Canada CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 37 Canada CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 38 Canada Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 39 Canada Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 40 Canada CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 41 Canada CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 42 Canada CTC market, by application, 2018 - 2030 (USD Million)
TABLE 43 Canada Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 44 Canada Research market, by application, 2018 - 2030 (USD Million)
TABLE 45 Canada CTC market, by product, 2018 - 2030 (USD Million)
TABLE 46 Canada CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 47 Europe CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 48 Europe CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 49 Europe Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 50 Europe Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 51 Europe CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 52 Europe CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 53 Europe CTC market, by application, 2018 - 2030 (USD Million)
TABLE 54 Europe Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 55 Europe Research market, by application, 2018 - 2030 (USD Million)
TABLE 56 Europe CTC market, by product, 2018 - 2030 (USD Million)
TABLE 57 Europe CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 58 UK CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 59 UK CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 60 UK Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 61 UK Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 62 UK CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 63 UK CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 64 UK CTC market, by application, 2018 - 2030 (USD Million)
TABLE 65 UK Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 66 UK Research market, by application, 2018 - 2030 (USD Million)
TABLE 67 UK CTC market, by product, 2018 - 2030 (USD Million)
TABLE 68 UK CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 69 Germany CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 70 Germany CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 71 Germany Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 72 Germany Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 73 Germany CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 74 Germany CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 75 Germany CTC market, by application, 2018 - 2030 (USD Million)
TABLE 76 Germany Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 77 Germany Research market, by application, 2018 - 2030 (USD Million)
TABLE 78 Germany CTC market, by product, 2018 - 2030 (USD Million)
TABLE 79 Germany CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 80 France CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 81 France CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 82 France Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 83 France Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 84 France CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 85 France CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 86 France CTC market, by application, 2018 - 2030 (USD Million)
TABLE 87 France Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 88 France Research market, by application, 2018 - 2030 (USD Million)
TABLE 89 France CTC market, by product, 2018 - 2030 (USD Million)
TABLE 90 France CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 91 Italy CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 92 Italy CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 93 Italy Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 94 Italy Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 95 Italy CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 96 Italy CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 97 Italy CTC market, by application, 2018 - 2030 (USD Million)
TABLE 98 Italy Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 99 Italy Research market, by application, 2018 - 2030 (USD Million)
TABLE 100 Italy CTC market, by product, 2018 - 2030 (USD Million)
TABLE 101 Italy CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 102 Spain CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 103 Spain CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 104 Spain Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 105 Spain Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 106 Spain CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 107 Spain CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 108 Spain CTC market, by application, 2018 - 2030 (USD Million)
TABLE 109 Spain Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 110 Spain Research market, by application, 2018 - 2030 (USD Million)
TABLE 111 Spain CTC market, by product, 2018 - 2030 (USD Million)
TABLE 112 Spain CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 113 Denmark CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 114 Denmark CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 115 Denmark Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 116 Denmark Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 117 Denmark CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 118 Denmark CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 119 Denmark CTC market, by application, 2018 - 2030 (USD Million)
TABLE 120 Denmark Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 121 Denmark Research market, by application, 2018 - 2030 (USD Million)
TABLE 122 Denmark CTC market, by product, 2018 - 2030 (USD Million)
TABLE 123 Denmark CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 124 Sweden CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 125 Sweden CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 126 Sweden Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 127 Sweden Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 128 Sweden CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 129 Sweden CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 130 Sweden CTC market, by application, 2018 - 2030 (USD Million)
TABLE 131 Sweden Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 132 Sweden Research market, by application, 2018 - 2030 (USD Million)
TABLE 133 Sweden CTC market, by product, 2018 - 2030 (USD Million)
TABLE 134 Sweden CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 135 Norway CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 136 Norway CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 137 Norway Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 138 Norway Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 139 Norway CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 140 Norway CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 141 Norway CTC market, by application, 2018 - 2030 (USD Million)
TABLE 142 Norway Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 143 Norway Research market, by application, 2018 - 2030 (USD Million)
TABLE 144 Norway CTC market, by product, 2018 - 2030 (USD Million)
TABLE 145 Norway CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 146 Asia Pacific CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 147 Asia Pacific CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 148 Asia Pacific Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 149 Asia Pacific Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 150 Asia Pacific CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 151 Asia Pacific CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 152 Asia Pacific CTC market, by application, 2018 - 2030 (USD Million)
TABLE 153 Asia Pacific Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 154 Asia Pacific Research market, by application, 2018 - 2030 (USD Million)
TABLE 155 Asia Pacific CTC market, by product, 2018 - 2030 (USD Million)
TABLE 156 Asia Pacific CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 157 Japan CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 158 Japan CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 159 Japan Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 160 Japan Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 161 Japan CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 162 Japan CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 163 Japan CTC market, by application, 2018 - 2030 (USD Million)
TABLE 164 Japan Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 165 Japan Research market, by application, 2018 - 2030 (USD Million)
TABLE 166 Japan CTC market, by product, 2018 - 2030 (USD Million)
TABLE 167 Japan CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 168 China CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 169 China CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 170 China Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 171 China Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 172 China CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 173 China CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 174 China CTC market, by application, 2018 - 2030 (USD Million)
TABLE 175 China Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 176 China Research market, by application, 2018 - 2030 (USD Million)
TABLE 177 China CTC market, by product, 2018 - 2030 (USD Million)
TABLE 178 China CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 179 India CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 180 India CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 181 India Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 182 India Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 183 India CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 184 India CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 185 India CTC market, by application, 2018 - 2030 (USD Million)
TABLE 186 India Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 187 India Research market, by application, 2018 - 2030 (USD Million)
TABLE 188 India CTC market, by product, 2018 - 2030 (USD Million)
TABLE 189 India CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 190 Australia CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 191 Australia CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 192 Australia Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 193 Australia Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 194 Australia CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 195 Australia CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 196 Australia CTC market, by application, 2018 - 2030 (USD Million)
TABLE 197 Australia Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 198 Australia Research market, by application, 2018 - 2030 (USD Million)
TABLE 199 Australia CTC market, by product, 2018 - 2030 (USD Million)
TABLE 200 Australia CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 201 Thailand CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 202 Thailand CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 203 Thailand Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 204 Thailand Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 205 Thailand CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 206 Thailand CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 207 Thailand CTC market, by application, 2018 - 2030 (USD Million)
TABLE 208 Thailand Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 209 Thailand Research market, by application, 2018 - 2030 (USD Million)
TABLE 210 Thailand CTC market, by product, 2018 - 2030 (USD Million)
TABLE 211 Thailand CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 212 South Korea CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 213 South Korea CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 214 South Korea Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 215 South Korea Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 216 South Korea CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 217 South Korea CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 218 South Korea CTC market, by application, 2018 - 2030 (USD Million)
TABLE 219 South Korea Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 220 South Korea Research market, by application, 2018 - 2030 (USD Million)
TABLE 221 South Korea CTC market, by product, 2018 - 2030 (USD Million)
TABLE 222 South Korea CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 223 Latin America CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 224 Latin America CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 225 Latin America Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 226 Latin America Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 227 Latin America CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 228 Latin America CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 229 Latin America CTC market, by application, 2018 - 2030 (USD Million)
TABLE 230 Latin America Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 231 Latin America Research market, by application, 2018 - 2030 (USD Million)
TABLE 232 Latin America CTC market, by product, 2018 - 2030 (USD Million)
TABLE 233 Latin America CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 234 Brazil CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 235 Brazil CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 236 Brazil Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 237 Brazil Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 238 Brazil CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 239 Brazil CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 240 Brazil CTC market, by application, 2018 - 2030 (USD Million)
TABLE 241 Brazil Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 242 Brazil Research market, by application, 2018 - 2030 (USD Million)
TABLE 243 Brazil CTC market, by product, 2018 - 2030 (USD Million)
TABLE 244 Brazil CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 245 Mexico CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 246 Mexico CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 247 Mexico Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 248 Mexico Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 249 Mexico CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 250 Mexico CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 251 Mexico CTC market, by application, 2018 - 2030 (USD Million)
TABLE 252 Mexico Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 253 Mexico Research market, by application, 2018 - 2030 (USD Million)
TABLE 254 Mexico CTC market, by product, 2018 - 2030 (USD Million)
TABLE 255 Mexico CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 256 Argentina CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 257 Argentina CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 258 Argentina Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 259 Argentina Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 260 Argentina CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 261 Argentina CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 262 Argentina CTC market, by application, 2018 - 2030 (USD Million)
TABLE 263 Argentina Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 264 Argentina Research market, by application, 2018 - 2030 (USD Million)
TABLE 265 Argentina CTC market, by product, 2018 - 2030 (USD Million)
TABLE 266 Argentina CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 267 Middle East & Africa CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 268 Middle East & Africa CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 269 Middle East & Africa Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 270 Middle East & Africa Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 271 Middle East & Africa CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 272 Middle East & Africa CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 273 Middle East & Africa CTC market, by application, 2018 - 2030 (USD Million)
TABLE 274 Middle East & Africa Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 275 Middle East & Africa Research market, by application, 2018 - 2030 (USD Million)
TABLE 276 Middle East & Africa CTC market, by product, 2018 - 2030 (USD Million)
TABLE 277 Middle East & Africa CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 278 South Africa CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 279 South Africa CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 280 South Africa Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 281 South Africa Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 282 South Africa CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 283 South Africa CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 284 South Africa CTC market, by application, 2018 - 2030 (USD Million)
TABLE 285 South Africa Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 286 South Africa Research market, by application, 2018 - 2030 (USD Million)
TABLE 287 South Africa CTC market, by product, 2018 - 2030 (USD Million)
TABLE 288 South Africa CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 289 Saudi Arabia CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 290 Saudi Arabia CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 291 Saudi Arabia Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 292 Saudi Arabia Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 293 Saudi Arabia CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 294 Saudi Arabia CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 295 Saudi Arabia CTC market, by application, 2018 - 2030 (USD Million)
TABLE 296 Saudi Arabia Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 297 Saudi Arabia Research market, by application, 2018 - 2030 (USD Million)
TABLE 298 Saudi Arabia CTC market, by product, 2018 - 2030 (USD Million)
TABLE 299 Saudi Arabia CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 300 UAE CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 301 UAE CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 302 UAE Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 303 UAE Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 304 UAE CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 305 UAE CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 306 UAE CTC market, by application, 2018 - 2030 (USD Million)
TABLE 307 UAE Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 308 UAE Research market, by application, 2018 - 2030 (USD Million)
TABLE 309 UAE CTC market, by product, 2018 - 2030 (USD Million)
TABLE 310 UAE CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 311 Kuwait CTC market, by technology, 2018 - 2030 (USD Million)
TABLE 312 Kuwait CTC Enrichment & Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 313 Kuwait Immunocapture/label-based market, by technology, 2018 - 2030 (USD Million)
TABLE 314 Kuwait Size-based separation/label-free market, by technology, 2018 - 2030 (USD Million)
TABLE 315 Kuwait CTC Direct Detection market, by technology, 2018 - 2030 (USD Million)
TABLE 316 Kuwait CTC Analysis market, by technology, 2018 - 2030 (USD Million)
TABLE 317 Kuwait CTC market, by application, 2018 - 2030 (USD Million)
TABLE 318 Kuwait Clinical/Liquid Biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 319 Kuwait Research market, by application, 2018 - 2030 (USD Million)
TABLE 320 Kuwait CTC market, by product, 2018 - 2030 (USD Million)
TABLE 321 Kuwait CTC market, by specimen, 2018 - 2030 (USD Million)
TABLE 322 Participant’s overview
TABLE 323 Financial performance
TABLE 324 Key companies undergoing expansions
TABLE 325 Key companies undergoing acquisitions
TABLE 326 Key companies undergoing collaborations
TABLE 327 Key companies launching new products/services
TABLE 328 Key companies undergoing partnerships

※본 조사보고서 [글로벌 순환 종양 세포 (CTC) 시장 (2023-2030) : 임상/액체 생검, 연구] (코드 : GRV23NOV011) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 순환 종양 세포 (CTC) 시장 (2023-2030) : 임상/액체 생검, 연구] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 iPS 세포 (유도 만능 줄기 세포) 시장 (2023-2030) : 간세포, 섬유 아세포
GRV23NOV022 / Grand View Research / 2023년 9월 / 글로벌 iPS 세포 (유도 만능 줄기 세포) 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 iPS 세포 (유도 만능 줄기 세포) 시장 규모는 2030년까지 30. 9억 달러에 달할...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 iPS 세포 (유도 만능 줄기 세포) 시장 : 유래세포 종류별 분석 Chapter 5. 세계의 iPS 세포 (유도 만능 줄기 세포) 시장 : 용도별 분석 Chapter 6. 세계의 iPS 세포 (유도 만능 줄기 세포) 시장...

글로벌 조직 투명화 시장 (2023-2030) : 기기, 키트 및 시약, 서비스
GRV23NOV168 / Grand View Research / 2023년 9월 / 글로벌 조직 투명화 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 조직 투명화 시장 규모는 2030년까지 2억 6,600만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 9. 24%의 성장률을...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 조직 투명화 시장 : 제품별 예측 및 동향 분석 Chapter 5. 세계의 조직 투명화 시장 : 조직 유형별 예측 및 동향 분석 Chapter 6. 세계의 조직 투명화 시장 : 용도별 예측 및...

글로벌 단일세포 게놈 시퀀싱 시장 (2023-2030) : 기기, 시약
GRV23NOV165 / Grand View Research / 2023년 9월 / 글로벌 단일세포 게놈 시퀀싱 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 단일세포 게놈 시퀀싱 시장 규모는 2030년까지 75억 5000만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 16....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 단일세포 게놈 시퀀싱 시장 : 제품 유형별 예측 및 동향 분석 Chapter 5. 세계의 단일세포 게놈 시퀀싱 시장 : 기술별 예측 및 동향 분석 Chapter 6. 세계의 단일세포 게놈 시퀀싱 시장 :...

글로벌 로봇 보조 내시경 시장 (2023-2030) : 병원, 외래 환자 시설
GRV23NOV241 / Grand View Research / 2023년 9월 / 글로벌 로봇 보조 내시경 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 로봇 보조 내시경 시장 규모는 2023년부터 2030년까지 연평균 8. 2%의 성장률을 기록하여 2030년에는 23억 6천만 달러에...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 로봇 보조 내시경 시장 : 최종 용도별 예측 및 동향 분석 Chapter 5. 세계의 로봇 보조 내시경 시장 : 지역별 예측 및 동향 분석 Chapter 6. 경쟁 현황...

글로벌 넓은 목근 성형 치료 시장 (2023-2030) : 남성, 여성
GRV23NOV231 / Grand View Research / 2023년 9월 / 글로벌 넓은 목근 성형 치료 시장의 성장과 동향 Grand View Research사의 새로운 보고서에 따르면, 세계의 넓은 목근 성형 치료 시장 규모는 2030년까지 18억 9,000만 달러에 달할 것으로 예상됩니다. 또한 2023년부터...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 넓은 목근 성형 치료 시장 : 성별 예측 및 동향 분석 Chapter 5. 세계의 넓은 목근 성형 치료 시장 : 최종 용도별 예측 및 동향 분석 Chapter 6. 세계의 넓은 목근 성형...